The new multidisciplinary approach, called “Molecular Tumor board”, arises from a collaboration of specialists and subspecialists, from a variety of fields, who meet to review and discuss cancer cases (general or site-specific), in order to provide the best treatment planning and reach a possibly better outcome for each cancer patient. Tumor Boards represent the involvement of all relevant disciplines in the treatment evaluation and planning process, allowing physicians to improve their approach to specific cancers by reviewing their cases and reconsidering changes in diagnosis and management, sharing them with all board members, and helping to ensure judicious use of health care resources. In this chapter, we aimed to summarize all the recent evidence on the molecular tumor board.

La Mantia M., Busuito G., Spinnato V., Gristina V., Galvano A., Cutaia S., et al. (2022). Molecular tumor board. In Liquid Biopsy: New Challenges in the era of Immunotherapy and Precision Oncology (pp. 211-219). Elsevier [10.1016/B978-0-12-822703-9.00006-5].

Molecular tumor board

Spinnato V.;Gristina V.;Galvano A.;Cutaia S.;Barraco N.;Cusenza S.;Incorvaia L.;Badalamenti G.;Russo A.;Bazan V.
2022-01-01

Abstract

The new multidisciplinary approach, called “Molecular Tumor board”, arises from a collaboration of specialists and subspecialists, from a variety of fields, who meet to review and discuss cancer cases (general or site-specific), in order to provide the best treatment planning and reach a possibly better outcome for each cancer patient. Tumor Boards represent the involvement of all relevant disciplines in the treatment evaluation and planning process, allowing physicians to improve their approach to specific cancers by reviewing their cases and reconsidering changes in diagnosis and management, sharing them with all board members, and helping to ensure judicious use of health care resources. In this chapter, we aimed to summarize all the recent evidence on the molecular tumor board.
2022
La Mantia M., Busuito G., Spinnato V., Gristina V., Galvano A., Cutaia S., et al. (2022). Molecular tumor board. In Liquid Biopsy: New Challenges in the era of Immunotherapy and Precision Oncology (pp. 211-219). Elsevier [10.1016/B978-0-12-822703-9.00006-5].
File in questo prodotto:
File Dimensione Formato  
Molecular tumor board.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 215.73 kB
Formato Adobe PDF
215.73 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/625457
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact